Detalhe da pesquisa
1.
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.
Cell
; 183(7): 1848-1866.e26, 2020 12 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-33301708
2.
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth.
Cell
; 162(6): 1242-56, 2015 Sep 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26359984
3.
Suppression by TFR cells leads to durable and selective inhibition of B cell effector function.
Nat Immunol
; 17(12): 1436-1446, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27695002
4.
In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target.
Nature
; 547(7664): 413-418, 2017 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28723893
5.
A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade.
Proc Natl Acad Sci U S A
; 117(38): 23684-23694, 2020 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907939
6.
Tracking mesenchymal stem cells with iron oxide nanoparticle loaded poly(lactide-co-glycolide) microparticles.
Nano Lett
; 12(8): 4131-9, 2012 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-22769232
7.
Monitoring PD-1 Phosphorylation to Evaluate PD-1 Signaling during Antitumor Immune Responses.
Cancer Immunol Res
; 9(12): 1465-1475, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635486
8.
Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells.
Cancer Immunol Res
; 9(2): 184-199, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277233
9.
Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations.
Cell Rep Methods
; 1(5): 100084, 2021 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474673
10.
PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.
J Exp Med
; 218(1)2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33045061
11.
Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses.
Sci Transl Med
; 13(581)2021 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33597266
12.
A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma.
Oncoimmunology
; 7(5): e1423172, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721378
13.
PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity.
J Exp Med
; 214(4): 895-904, 2017 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28302645
14.
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
J Exp Med
; 212(10): 1603-21, 2015 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26371185
15.
Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade.
Cancer Immunol Res
; 2(7): 643-54, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24903021
16.
BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes.
Oncoimmunology
; 2(10): e26615, 2013 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251082
17.
Clonal growth of dermal papilla cells in hydrogels reveals intrinsic differences between Sox2-positive and -negative cells in vitro and in vivo.
J Invest Dermatol
; 132(4): 1084-93, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22189784
18.
p73 expression and function in vestibular schwannoma.
Arch Otolaryngol Head Neck Surg
; 135(7): 662-9, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19620587